Mosaic Immunoengineering (CPMV) Stock Price, News & Analysis
Company Description
Mosaic Immunoengineering (OTC Link: CPMV) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $4.9M.
CPMV has declined 34.0% over the past year. Shares last traded at $0.3326.
For FY2025, Mosaic Immunoengineering and diluted earnings per share of $-0.10.
This page collects what Stock Titan holds for CPMV, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Mosaic Immunoengineering (CPMV) stock last closed at $0.3326. Over the past 12 months, the stock has lost 34.0%. At a market capitalization of $4.9M, CPMV is classified as a micro-cap stock with approximately 7.2M shares outstanding.
Latest News
Mosaic Immunoengineering has 10 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 2 with negative movement. Key topics include acquisition, conferences. View all CPMV news →
SEC Filings
Mosaic Immunoengineering has filed 5 recent SEC filings, including 2 Form 10-Q, 1 Form NT 10-Q, 1 Form 10-K, 1 Form NT 10-K. The most recent filing was submitted on May 20, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all CPMV SEC filings →
Financial Highlights
Diluted earnings per share stood at $-0.10. With a current ratio of 0.00, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in Mosaic Immunoengineering (CPMV) currently stands at 1.3 thousand shares, down 3.2% from the previous reporting period, representing 0.2% of the float. Since September 2025, short interest has increased by 140.1%. This relatively low short interest suggests limited bearish sentiment. The 8.1 days to cover indicates moderate liquidity for short covering.
Days to Cover History
Days to cover for Mosaic Immunoengineering (CPMV) currently stands at 8.1 days, down 98.2% from the previous period. This moderate days-to-cover ratio suggests reasonable liquidity for short covering, requiring about a week of average trading volume. The days to cover has increased 709% over the past year, indicating improving liquidity conditions. The ratio has shown significant volatility over the period, ranging from 1.0 to 443.0 days.
CPMV Company Profile & Sector Positioning
Mosaic Immunoengineering (CPMV) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing CPMV often look at related companies in the same sector, including Restart Life (NMLSF), Avenue Therapeutics Inc (ATXI), Nascent Biotech (NBIO), Mynd Life Scienc (MYNDF), and GREY MATTERS HEALTH INC, (AGNPF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CPMV's relative position within its industry.